Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda includes catching up on our reading, promenading a few miles with the official mascot, and taking a few naps. And what about you? This may be a good time to touch base with those feeling isolated, or you can support the local economy by placing an order with a nearby restaurant. You may also want to check on when you can get vaccinated. Well, whatever you do, have a grand time. But be safe — wear a mask. Enjoy, and see you soon. …

Pfizer (PFE) and BioNTech (BNTX) agreed to supply their Covid-19 vaccine to the COVAX vaccine access scheme co-led by the World Health Organization, the latest in a series of shots to be included in the project aimed at lower-income countries, Reuters reports. Details on the size of the deal or the price per dose COVAX would pay were not immediately clear, but the allotment would likely be relatively small, because the doses are primarily meant for health care workers in the countries that COVAX serves.


Meanwhile, Pfizer has slashed in half the volume of Covid-19 vaccines it will deliver to some European Union countries this week, as frustration over an unexpected cut in supplies grows, Reuters tells us. With governments across the region still reeling from the surprise cuts, officials say the reductions are undermining their efforts to inoculate their citizens and tame the pandemic that has killed more than 2 million people. Adding to the upheaval are worries about supplies of special syringes needed to extract six doses from each vial of the shot.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!